St. Petersburg Research Institute of Vaccines and Serums will produce more than 20 million doses of preventive flu vaccines.
This epidemiological season SPbSRIVS will produce and deliver to Nacimbio (National Immunobiological Company) 20 million doses of preventive flu vaccines following the National calendar of vaccination.
“First 6 millions of doses had been already shipped to the single supplier of the national calendar; the rest of the vaccine will be produced and delivered according to schedule. Our vaccine showed good results last year, which allowed our company to maintain the position of the largest Russian manufacturer of flu vaccine”, – said Mr. Victor Trukhin, Director of SPbSRIVS.
In addition, this year SPbSRIVS will ship preventive flu vaccines to the countries of Latin America in the amount of 967 thousand doses. Russian vaccine will be used to prevent influenza in Cuba and Nicaragua, where Federal Medical and Biological Agency is realizing the project of establishing Russia – Nicaragua Latin American Biotechnology Institute MECHNIKOV and the transfer of vaccine production technology for the prevention of influenza. “We are sincerely grateful to our partners in Latin America for their cooperation, which has been developing steadily for three years already. SPbSRIVS is ready to satisfy completely the demands of Ministry of Heath of Cuba and Nicaragua in preventive flu vaccines. It is important that our vaccine proved its efficiency and safety in different countries. This is a result of usage of unique technology and quality control of the medicine at all stages of production”, – commented Mr. Victor Trukhin, Director of SPbSRIVS.